Mojirade James - Mar 6, 2023 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, General Counsel
Signature
/s/ John Hurley, as attorney-in-fact for Mojirade James
Stock symbol
AVNS
Transactions as of
Mar 6, 2023
Transactions value $
-$62,528
Form type
4
Date filed
3/7/2023, 03:51 PM
Previous filing
Jul 22, 2022
Next filing
Jul 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +20.3K +75.67% $0.00 47.2K Mar 6, 2023 Direct F1
transaction AVNS Common Stock Tax liability -$62.5K -2.11K -4.47% $29.62 45.1K Mar 6, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.